Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 6/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.37 |
| ▸ | AKR1B10 | O60218 | 3/20 | 0.37 |
| ▸ | AKR1B1 | P15121 | 3/20 | 0.37 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.37 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.34 |
| ▸ | GPBAR1 | Q8TDU6 | 2/20 | 0.33 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | SERPINA6 | P08185 | 1/20 | 0.33 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17988645 | 1.00 | SHBG (0.38) | SHBGCYP19A1AKR1B10AKR1B1OR51E2 | |
| SCHEMBL16504348 | 0.89 | CYP19A1 (0.34) | SHBGCYP19A1AKR1B10AKR1B1OR51E2 | |
| SCHEMBL2457859 | 0.82 | — | — | |
| SCHEMBL17048771 | 0.82 | — | — | |
| SCHEMBL2455331 | 0.82 | — | — | |
| SCHEMBL2455329 | 0.82 | — | — | |
| SCHEMBL9314092 | 0.77 | CYP19A1 (0.38) | SHBGCYP19A1AKR1B10AKR1B1OR51E2 | |
| SCHEMBL7436315 | 0.73 | — | — | |
| SCHEMBL2248516 | 0.71 | SHBG (0.36) | SHBG | |
| SCHEMBL2495783 | 0.71 | SHBG (0.36) | SHBG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240166588-A1 | THE OXIDATION OF CARBON-HYDROGEN BONDS USING OZONE | P2 SCIENCE, INC. | 2024-05-23 | — | — | US | disclosed |
| WO-2022192578-A1 | THE OXIDATION OF CARBON-HYDROGEN BONDS USING OZONE | P2 SCIENCE, INC. (US) | 2022-09-15 | — | — | WO | disclosed |
| US-6916838-B1 | 1-benzylpyrazole-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists | SANOFI-AVENTIS (FR) | 2005-07-12 | — | — | US | disclosed |
| EP-1230222-B1 | 1-BENZYLPYRAZOLES-3-CARBOXYLIC ACID TRICYCLIC DERIVATIVES AS CANNABINOID RECEPTOR ANTAGONISTS | SANOFI SYNTHELABO (FR) | 2004-07-07 | — | — | EP | disclosed |
| EP-1230222-A1 | 1-BENZYLPYRAZOLES-3-CARBOXYLIC ACID TRICYCLIC DERIVATIVES AS CANNABINOID RECEPTOR ANTAGONISTS | SANOFI-SYNTHELABO (FR) | 2002-08-14 | — | — | EP | disclosed |
| WO-2001032629-A1 | 1-BENZYLPYRAZOLES-3-CARBOXYLIC ACID TRICYCLIC DERIVATIVES AS CANNABINOID RECEPTOR ANTAGONISTS | SANOFI-SYNTHELABO (FR) | 2001-05-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240166588-A1 | THE OXIDATION OF CARBON-HYDROGEN BONDS USING OZONE | GPX4, NOX4, SCO2 | SHBG 198/4885CYP19A1 387/4885AKR1B10 1137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.